Connors Investor Services’s ResMed RMD Stock Holding History

Connors Investor Services’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,000	Closed	-$258K	–	166
2025 Q2	$258K	Hold	1,000	–	–	0.02%	127
2025 Q1	$224K	Hold	1,000	–	–	0.02%	133
2024 Q4	$229K	Hold	1,000	–	–	0.02%	139
2024 Q3	$244K	Buy	+1,000	New	+$223K	0.02%	135
2023 Q3	–	Sell	-1,000	Closed	-$219K	–	162
2023 Q2	$219K	Hold	1,000	–	–	0.02%	141
2023 Q1	$219K	Hold	1,000	–	–	0.03%	146
2022 Q4	$208K	Hold	1,000	–	–	0.03%	142
2022 Q3	$218K	Hold	1,000	–	–	0.03%	130
2022 Q2	$210K	Hold	1,000	–	–	0.03%	136
2022 Q1	$243K	Hold	1,000	–	–	0.03%	138
2021 Q4	$260K	Hold	1,000	–	–	0.03%	136
2021 Q3	$264K	Hold	1,000	–	–	0.03%	138
2021 Q2	$247K	Sell	1,000 -300	-23%	-$63.1K	0.03%	145
2021 Q1	$252K	Buy	+1,300	New	+$261K	0.03%	137

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Connors Investor Services's RMD Position: Q3 2025 in Review

Connors Investor Services sold out of ResMed (RMD) in Q3 2025, closing a stake of 1,000 shares — an estimated $258K sold.

Connors Investor Services first reported a position in RMD in Q1 2021 and held it in 14 quarters. The position peaked at $264K in Q3 2021. 950 funds tracked by Wall St. Rank hold RMD as of Q3 2025.

Connors Investor Services reported no remaining ResMed position as of Q3 2025 after selling out during the quarter.
Connors Investor Services sold 1,000 ResMed shares in Q3 2025, an estimated $258K.
Connors Investor Services first reported a position in ResMed in Q1 2021 and held it in 14 quarters.
Connors Investor Services's ResMed position peaked at $264K in Q3 2021.
950 funds tracked by Wall St. Rank held ResMed as of Q3 2025.

Based on Connors Investor Services's 13F filing for Q3 2025, filed 25 Nov 2025.